![396. Describe the P waves in sinus tachycardia / When a beta blocker is indicated in sinus tach / Ddx sinus tach – emupdates 396. Describe the P waves in sinus tachycardia / When a beta blocker is indicated in sinus tach / Ddx sinus tach – emupdates](https://i0.wp.com/emupdates.com/wp-content/uploads/2008/07/emcard0792.jpg)
396. Describe the P waves in sinus tachycardia / When a beta blocker is indicated in sinus tach / Ddx sinus tach – emupdates
![Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias | AER Journal Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias | AER Journal](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/table-5-therapy-of-sinus-tachycardia.png)
Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias | AER Journal
![Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41371-021-00505-8/MediaObjects/41371_2021_505_Fig1_HTML.png)
Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension
![Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: A systematic review - ScienceDirect Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: A systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0300957212000433-gr1.jpg)
Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: A systematic review - ScienceDirect
![2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm](https://www.jacc.org/cms/asset/be126f80-db9f-4b86-8476-b627128f04fa/gr21.jpg?download)
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm
![Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation: A Systematic Review and Meta-analysis of Randomized Controlled Trials - ScienceDirect Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation: A Systematic Review and Meta-analysis of Randomized Controlled Trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369221000350-gr1.jpg)
Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation: A Systematic Review and Meta-analysis of Randomized Controlled Trials - ScienceDirect
![Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre | BMC Cardiovascular Disorders | Full Text Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre | BMC Cardiovascular Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12872-020-01843-0/MediaObjects/12872_2020_1843_Fig1_HTML.png)